These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 35364307)

  • 1. Survival risk prediction model for ESCC based on relief feature selection and CNN.
    Wang Y; Zhu C; Wang Y; Sun J; Ling D; Wang L
    Comput Biol Med; 2022 Jun; 145():105460. PubMed ID: 35364307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survival prediction model based on PCA-HSIDA-LSSVM for patients with esophageal squamous cell carcinoma.
    Wang Y; Xia Y; Ling D; Sun J; Wang Y
    Proc Inst Mech Eng H; 2023 Dec; 237(12):1409-1426. PubMed ID: 37877733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convolutional neural network model for survival prediction based on prognosis-related cascaded Wx feature selection.
    Yin Q; Chen W; Zhang C; Wei Z
    Lab Invest; 2022 Oct; 102(10):1064-1074. PubMed ID: 35810236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-dimensional convolutional neural network based deep learning for high accuracy classification of transformation stages in esophageal squamous cell carcinoma tissue using micro-FTIR.
    Yang H; Li X; Zhang S; Li Y; Zhu Z; Shen J; Dai N; Zhou F
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Mar; 289():122210. PubMed ID: 36508904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of IDPC Clustering Analysis and Interpretable Machine Learning for Survival Risk Prediction of Patients with ESCC.
    Ling D; Liu A; Sun J; Wang Y; Wang L; Song X; Zhao X
    Interdiscip Sci; 2023 Sep; 15(3):480-498. PubMed ID: 37248421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Prediction Model for Patients with Esophageal Squamous Cell Carcinoma Based on the Parameter-Optimized Deep Belief Network Using the Improved Archimedes Optimization Algorithm.
    Wang Y; Zhang W; Sun J; Wang L; Song X; Zhao X
    Comput Math Methods Med; 2022; 2022():1924906. PubMed ID: 35844460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning‑based prediction of survival prognosis in esophageal squamous cell carcinoma.
    Zhang K; Ye B; Wu L; Ni S; Li Y; Wang Q; Zhang P; Wang D
    Sci Rep; 2023 Aug; 13(1):13532. PubMed ID: 37598277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing a survival prediction model for esophageal squamous cell carcinoma based on CT and histopathological images.
    Wang J; Wu LL; Zhang Y; Ma G; Lu Y
    Phys Med Biol; 2021 Jul; 66(14):. PubMed ID: 34192686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A variable structure fuzzy neural network model of squamous dysplasia and esophageal squamous cell carcinoma based on a global chaotic optimization algorithm.
    Moghtadaei M; Hashemi Golpayegani MR; Malekzadeh R
    J Theor Biol; 2013 Feb; 318():164-72. PubMed ID: 23174279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The association between the whole blood riboflavin level and the occurrence, development and prognosis of esophageal squamous cell carcinoma].
    Li SS; Tan HZ; Xu YW; Wu ZY; Wu JY; Zhao XK; Wang LD; Long L; Li EM; Xu LY; Zhang JJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1124-1129. PubMed ID: 31683399
    [No Abstract]   [Full Text] [Related]  

  • 12. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
    Li MX; Sun XM; Cheng WG; Ruan HJ; Liu K; Chen P; Xu HJ; Gao SG; Feng XS; Qi YJ
    BMC Cancer; 2021 Aug; 21(1):906. PubMed ID: 34372798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.
    Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ
    Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
    Zhao X; Tang YP; Wang CY; Wu JX; Ye F
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyk2 level is a novel prognostic marker for patients with esophageal squamous cell carcinoma after radical surgery.
    Zhu T; Yang Q; Shao J; Chen Z; Cai B; Mao G
    Virchows Arch; 2021 Nov; 479(5):905-917. PubMed ID: 34313839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
    Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
    BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Prognostic Value of LRG1 in Esophageal Squamous Cell Carcinoma.
    Wang Y; Xing Q; Chen X; Wang J; Guan S; Chen X; Sun P; Wang M; Cheng Y
    Curr Cancer Drug Targets; 2019; 19(9):756-763. PubMed ID: 30714525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.